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O R I G I N A L  A R T I C L E
INTRODUCTION: Acute ischemic stroke is considered 
as one of the most common fatal diseases, in our 
times.1 Those who survive strokes, suffer from their 
undesirable outcomes that include the subsequent 
long-term or sometimes life-long disability 1 which 
constitutes a significant burden on patients’ personal 
well-being and on the care givers as well. Stroke 
severity is one of the factors associated with disability 2. 
Stroke severity can be assessed and measured by 
clinical examination. There are many scoring systems 
that quantify or measure stroke severity. One of these is 
National Institute of Health Stroke Scale (NIHSS), 
which is a validated and a widely used scoring system 
for this purpose.3 Currently, acute thrombolysis, 
revascularization, prophylaxis (preventing first or further 
strokes) and rehabilitation are the main domains of 
stroke therapy. We believe that identifying reversible 
factors that may play a role in reducing stroke severity 
Statistical analysis:
Data analysis was done by using SPSS version-20.0 
([IBM Product-USA]). The categorical response 
variables included patient’s demographic features, 
etiology of stroke, co- morbid conditions, family history, 
clinical features and severity of stroke. The numeric 
response variables like fasting triglyceride and other 
lipid levels, HbA1c, random blood sugar ([RBS]), 
Systolic Blood Pressure, and fasting lipid profile were 
presented as mean (standard deviation). Analysis of 
variance ([ANOVA]) was performed to compare these 
numeric response variables. Later, these numeric 
variables were stratified in order to control the 
confounding effect and effect modifiers. Stroke severity 
was also stratified into three categories i.e., mild, 
moderate and severe. Bivariate analysis by using 
Chi-square test was done to see relationship of 
aforementioned variables with the severity of stroke 
measured by NIHSS and divided into categories. 
Pearson’s correlation coefficient was calculated to see 
the relationship of triglyceride level with the NIHSS. 
P-value ≤.05 was considered statistically significant 
result.
RESULTS:
Baseline characteristics of patients:
Total 207 patients were selected after applying the 
inclusion and exclusion criteria. The mean ([SD]) age of 
patients was 63.5 ([13.7]) yrs. ([range 26 yrs. – 95 
yrs.]). There were 117 ([56.5 %]) males and 90 ([43.5 
%]) females. Among males mean ([SD]) age was 64.1 
([13.6]) yrs., and that of females was 62.8 ([13.8]) 
yrs.The age distribution was not uniform among 
different stroke etiologies. The mean age in unclassified 
stroke type ([more than one etiologies]) was 70 yrs. 
that was highest than the rest of stroke types, while the 
mean age in uncommon causes of stroke was 34 years 
that was significantly lower than the other stroke types. 
According to stroke etiology most of the patients were 
in supra aortic large artery atherosclerosis that totaled 
98 ([47.3%]) patients, followed by, Cardio embolism in 
40 ([19.3%]) patients, small artery occlusion in 22 
([10.6 %]) patients, cryptogenic type in 21 ([10.1 %]), 
unclassified in 20 ([9.7 %]),  and uncommon causes in 
5 ([2.4 %]), of patients. One patient had incomplete 
evaluation.
Stroke severity analysis:
When stroke severity was taken as mean NIHSS or as 
NIHSS categories ([mild, moderate or severe]), the 
results appeared similar (see Table 1 and figure 1). 
Higher number of patients were in moderate to severe 
category in cardio  embolic strokes ([mean NIHSS 
10.4]) and unclassified ([mean NIHSS 9.3]) stroke 
types. Small vessel occlusion type strokes had the 
lowest severity. When stroke severity ([mean NIHSS 
and/or NIHSS categories]) was compared with all 
variables other than stroke etiology, significant 
associations were found only with age and fasting 
triglyceride levels. Stroke severity was found to be 
higher with advancing age.  NIHSS scores were 
significantly lower with higher triglyceride levels and vice 
versa. ([see table 2 and figure 2]). When radiological 
features were compared to stroke severity ([Table 3]) it 
was found that higher stroke severity was associated 
with whole MCA territory / malignant MCA infarctions, 
while partial MCA infarctions were less severe. MRI DWI 
(Diffusion Weighted Imaging) assessment showed that 
large sized infarctions with more than 15 mm size 
([territorial, lobar or deep subcortical]) and those with 
hemorrhagic conversion, were more likely to be 
moderate or severe.
Sub category analysis ([stroke severity analysis by 
stroke etiology]):
We analyzed the relationship of different variables with 
stroke severity categories, in each stroke type / etiology. 
In this analysis  we found that only the Supra Aortic 
Large artery atherosclerosis and cryptogenic types 
([Table 4]) had the inverse relationship between stroke 
severity and triglyceride levels ([P = .04]). Apparently 
triglyceride levels did not produce similar effect on 
stroke severity in cardio aortic embolism and small 
vessel occlusion. In this sub category analysis, we also 
found that the pre-stroke anti platelet ([aspirin, 
clopidogrel or both]) and beta blocker use ([Table 5]) 
was significantly associated with lower stroke severity 
only in Supra Aortic Large artery atherosclerosis 
([P=.02]). In cardio aortic embolic strokes 10 patients 
were actively smoking out of which 6 patients suffered 
from severe stroke, 3 patients with moderate stroke 
and only one had mild stroke ([P=.03]).  
DISCUSSION:
In this exploratory study we compared many different 
characteristics of patients with acute ischemic stroke 
and analyzed them for their relationship with stroke 
severity. The stroke etiology / type, as is already known, 
was one of the main factors related to stroke severity 
([table 1]). The cardio aortic embolism and unclassified 
type (more than one etiology) were associated with 
more severe strokes, while supra aortic large artery 
atherosclerosis mostly with moderate severity and 
cryptogenic strokes, small artery occlusion, and 
FACTORS INFLUENCING SEVERITY IN ACUTE ISCHEMIC
STROKES
ABSTRACT:
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may give us clues to look for novel neuroprotection and 
possibly disease modifying strategies. We designed our 
research work as an exploratory study, aiming to 
observe relationships between  the clinical, laboratory 
and radiological features, and stroke severity among 
ischemic stroke patients. We identified clinical 
characteristics that are usually evaluated for nearly all 
hospitalized patients suffering ischemic stroke, and 
analyzed them for any significant relationship with 
stroke severity as measured by NIHSS. Given possibility 
of confounding factors and limitations of NIHSS we 
restricted our study only for ischemic strokes in middle 
cerebral artery ([MCA]) distribution.
 
METHODS:
This study was designed as an exploratory retrospective 
cross sectional survey. It was carried out in the 
department of Neurology, at Shifa International 
Hospital, Islamabad, Pakistan which is one of the 
largest tertiary care hospitals in the capital city.  The 
research protocol was approved by the Institutional 
Review Board of the same hospital. Only adult patients 
([18 years and above]) admitted in the neurology 
service, with the diagnosis of acute Middle Cerebral 
Artery (MCA) ischemic stroke (territorial or lacunar 
infarcts in MCA distribution), within three days of onset 
of ischemic symptoms over a period of 39 months 
([September 2009 to November 2012]) were 
considered. During the study period Intravenous tissue 
plasminogen activator, acute endovascular 
intervention, were not available in our hospital, 
therefore none of the patients received acute 
thrombolytic therapy. Patients with posterior circulation 
ischemia, having history of previous stroke, and those 
suffering from any disabling neurological disease other 
than stroke were excluded as the patients with previous 
strokes, and having a baseline neurological deficit may 
have a more severe deficit, because of the recurrent 
stroke, which may not be related to the more acute 
laboratory findings that we measured. The file records 
of selected patients were extracted and relevant clinical 
information pertaining to first 24 hours of hospital 
admissions was obtained. The laboratory values were 
taken from Hospital Information System (HIS), and 
radiological data was reviewed from Picture Archiving 
and Communication System ([PACS]) of the hospital. 
For etiological classification of stroke the online 
Causative Classification of Ischemic Stroke ([CSS]) 
System was used 4. The information thus obtained was 
entered in a predesigned data sheet. At the completion 
of the data collection all the data was entered in SPSS 
20. All the case histories, laboratory data in first 24 
hours of admission, and radiological information was 
reviewed and analyzed by a consultant neurologist and 
statisticians.
Operational definitions: 
1. Acute MCA ischemic stroke: An acute event that was 
diagnosed by the attending neurologist as ischemic 
stroke ([with or without hemorrhagic conversion]) and 
corresponds to areas supplied by middle cerebral artery 
and/ or its smaller perforator branches which was 
further radiologically confirmed by MRI ([DWI/ ADC 
sequences]) or CT scans.
2. Co- morbid hypertension: The file records showed 
that the patient was known to be hypertensive and he 
was on regular anti-hypertensive therapy, or was found 
to have a blood pressure of 160 mmHg / 90 mmHg or 
more on admission, that was not considered by the 
attending physician as transient rise due to cerebral 
compensating mechanisms.
3. Co- morbid diabetes: The file records showed 
that the patient was known to be diabetic and he/ she 
was taking regular anti diabetic medications, or his 
HbA1c was 6.5 % or more.
4. Co – morbid Ischemic heart disease and 
chronic renal failure: The patient was labelled to have 
above mentioned co-morbid conditions in the file 
records, diagnosed on the basis of clinical, 
electrocardiographic, biochemical, echocardiographic 
and ultra-sonographic investigations.
Categories by stroke etiology / stroke type:
We utilized the online software, CCS ([which is derived 
from TOAST classification]) to determine the stroke type 
by its etiology. 4 However we made some modifications 
in this classification system, so that statistical analyses 
were possible as some of the categories had very low 
number of patients.  In the original CCS classification 
there are 5 major categories and 4 subcategories. But, 
in our study we merged some of the subcategories and 
thus made in total 6 categories ([without any 
subcategories]) at the time of analyses of the data 
([table 1]). The subtype “unknown – cryptogenic 
embolism” and “unknown- other cryptogenic” in CCS 
were also combined together into cryptogenic type. The 
category “Unclassified” was used when more than one 
etiologies are identifiable in the same patient ([same as 
in original CCS classification]).  
Categories by stroke severity: 
Determined by NIHSS score. They were as follows5 ;
Mild: < 5, Moderate: 5- 14, Severe: ≥ 15 
V O L .  1 5  ( 2 )   A P R I L - J U N E  2 0 2 0
Inam E Khuda1, Intisar Siddiqui2, Saad Munzar3, Rashid Nazir4, Arsalan Ahmed5
1Department of Neurology, King Fahd Hospital of University, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam,
Saudi Arabia. 2Department of Dental Education, College of Dentistry, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
3,4,5Department of Neurology Shifa International Hospital, Shifa Tameer-e-Millat University, Islamabad, Pakistan.
uncommon causes were associated with predominantly 
lower stroke severity. Similar results have been shown 
in other studies6,7. Furthermore the triglyceride levels 
were found to be inversely related to stroke severity, as 
the higher triglyceride levels were significantly 
associated with lower stroke severity and vice versa 
([table 2 and figure 2]). In fact, the role of higher serum 
triglycerides in reducing the stroke severity is a relatively 
novel concept, as hypertriglyceridemia is considered a 
risk factor for stroke. The association of triglyceride 
levels in blood, with stroke severity and outcome has 
emerged in a few other recently published studies8. 
Dziedzic et al., correlated the Scandinavian stroke scale 
([which is another measure of stroke severity])  to 
triglyceride levels, and concluded that lower triglyceride 
levels were associated with increased stroke severity9. 
A prospective study by Ryu etal, reported that higher 
fasting triglycerides on admission predict less disability, 
reduced disability progression, and all-cause mortality 
in patients with acute ischemic stroke10. Another study 
by Choi etal also confirmed that low serum triglyceride 
level is an independent predictor of mortality after 
ischemic stroke, but noted that this association did not 
hold true in the subgroup with cardioembolic stroke11. 
History of dyslipidemia was found to have a favorable 
effect on out come in ischemic stroke patients in Kyoto 
stroke registry12.  In one study higher cholesterol levels 
were also reported to be associated more frequently 
with minor strokes13. Our study elaborates this unusual 
phenomenon, as we further analyzed the distribution of 
triglycerides levels among different stroke severity 
categories in each stroke etiology/ type. What appeared 
in this later analysis is that the effect of serum 
triglyceride levels (as mentioned above) was significant 
only in supra aortic large artery atherosclerosis and 
cryptogenic types (table 4). The other types including 
cardioaortic embolic and small artery occlusion stroke 
types were not affected by triglyceride levels. The loss 
of this triglyceride effect in cardio aortic embolic strokes 
was also seen by  Choi etal ([see above])11. Current 
stroke pathophysiology models do not explain this 
phenomenon, as hypertriglyceridemia is actually 
considered a risk factor for stroke because of its long 
term effects on vascular endothelium. There can be 
many explanations for this associations. (1) Some 
authors consider serum triglycerides as an acute phase 
reactant that is decreased in severe strokes as a result 
of cerebral ischemia and perhaps may not actually have 
a direct protective effect against cerebral neuronal 
damage8. (2) Another likely possibility, though 
debatable, is the fact that high lipid containing plaque / 
clot is very likely to be friable, and thus embolise easily 
into more distal cerebral vasculature thus it may cause 
more incident stroke but that of lesser severity.(3) There 
is also a possibility that high lipids especially 
triglycerides, may have a more positive role in acute 
ischemic strokes.  It is a well-known fact that fats in 
general have a favorable effect on brain metabolism. 
For example; fatty diets like ketogenic diet is well known 
to have a therapeutic effect in refractory epilepsy in 
children, 14 although similar diet has not been 
thoroughly evaluated in adults with stroke or epilepsy. 
Thus more research is needed to elucidate the role of 
lipids/ triglycerides in during the acute phases of 
ischemic stroke. In supra aortic large artery 
atherosclerotic strokes pre stroke antiplatelet (aspirin, 
clopidogrel or both) and beta blocker use was 
significantly associated with lower stroke severity 
([table 5]). Aspirin use before stroke has been shown to 
have a beneficial effect in some other studies as similar 
findings were reported by Park etal 15 in 
atherothrombotic stroke. Same effect could not be 
seen in cardio aortic embolism and other stroke types 
16,17. The effect of beta blockers (propranolol and 
carvedilol) on brain ischemia has been shown in 
experimental models of stroke that suggest a 
neuroprotective effect on cerebral neurons18-20. 
Dziedzic T et al, found lower rates of early mortality after 
ischemic stroke in patients taking beta blockers, 
however, they did not report any effect on stroke 
severity22. They did not take stroke etiology into 
account, in their patients. Active current smoking was 
also found to be related to increased stroke severity in 
cardioembolic stroke but not in other types. Similar 
findings were reported by Edjoc etal.22 Among the 
radiological features, it was the size and not the site of 
the infarction that was mainly associated with stroke 
severity ([table 3]). In plain CT brain and MRI scans the 
whole MCA territory and malignant MCA infarctions had 
significantly higher stroke severity, while among the 
different MRI DWI patterns we found only the large ([> 
15 mm in size]) pattern irrespective of the location 
(lobar or deep subcortical) had significant association 
with severe strokes.
Weaknesses:
The study was a retrospective analysis with an 
exploratory design. We preferred such a study design 
because; (1) we were not testing any hypothesis, rather 
we aimed to look into possible novel strategies for 
neuroprotection that might generate newer 
studies.(2)The authors found it more feasible because 
of the limited resources at their disposal. Furthermore, 
a multivariate analysis could not be performed for 
specification of potential confounding effect and 
predictors of stroke severity due to design of study. 
Rather, we used restriction and stratification 
strategies in data selection and analysis to control for 
possible confounders. 
We also did not have the pre stroke or baseline 
triglyceride levels of our subjects, which was 
practically not possible either, therefore the theory of 
acute phase reaction to explain the inverse 




In spite of all the weaknesses we think that this study 
provides valuable information. Furthermore we 
analyzed our variables in different subsets and found 
that the relationship between stroke severity and 
triglyceride levels, pre-stroke anti platelet as well as 
beta blocker use and smoking, seemingly depends 
upon the etiological category of the stroke, a fact not 
particularly looked into as yet.
CONCLUSION:
Stroke severity is related to age and its etiology. There 
is also a possible inverse correlation between stroke 
severity and fasting triglyceride levels, which is seen 
predominantly in supra aortic large artery 
atherosclerotic and cryptogenic stroke etiologies. 
People who suffer ischemic strokes due to supra 
aortic large artery atherosclerosis, with pre-stroke use 
of anti-platelets and beta blockers, also seem to have 
a reduced stroke severity. Furthermore, patients who 
actively smoke may have more severe strokes, if they 
have a cardio embolic etiology. We would recommend 
future studies to verify if factors we found have a 
consistent causal association, in the context of 
different stroke etiologies.  
Table 1: stroke severity by categories vs stroke 
etiology.
*Shows statistically significant proportion of severity 
of stroke with stroke types (P<.001)
Figure 1 : Mean NIHSS score Difference 
according to stroke etiology
Bar graph showing significant mean NIHSS score 
associated with stroke sub-types ([F= 6.317, 
P=.001]). Cardio aortic embolic strokes and 
unclassified strokes had the highest severity. 
Table 2 : stroke severity as compared to different 
variables:
Figure 2 : Scatter plot showing inverse relationship 
between NIHSS at admission and triglyceride 
levels
Table 3 : Radiological features vs stroke severity
*significant values.
Table 4 : Mean Triglyceride levels in different 
stroke categories
Table 5: impact of pre-stroke medicines and stroke 
severity
a Statistical significance using Pearson’s chi-square 
test b Fischer’s exact test.
Statistical analysis:
Data analysis was done by using SPSS version-20.0 
([IBM Product-USA]). The categorical response 
variables included patient’s demographic features, 
etiology of stroke, co- morbid conditions, family history, 
clinical features and severity of stroke. The numeric 
response variables like fasting triglyceride and other 
lipid levels, HbA1c, random blood sugar ([RBS]), 
Systolic Blood Pressure, and fasting lipid profile were 
presented as mean (standard deviation). Analysis of 
variance ([ANOVA]) was performed to compare these 
numeric response variables. Later, these numeric 
variables were stratified in order to control the 
confounding effect and effect modifiers. Stroke severity 
was also stratified into three categories i.e., mild, 
moderate and severe. Bivariate analysis by using 
Chi-square test was done to see relationship of 
aforementioned variables with the severity of stroke 
measured by NIHSS and divided into categories. 
Pearson’s correlation coefficient was calculated to see 
the relationship of triglyceride level with the NIHSS. 
P-value ≤.05 was considered statistically significant 
result.
RESULTS:
Baseline characteristics of patients:
Total 207 patients were selected after applying the 
inclusion and exclusion criteria. The mean ([SD]) age of 
patients was 63.5 ([13.7]) yrs. ([range 26 yrs. – 95 
yrs.]). There were 117 ([56.5 %]) males and 90 ([43.5 
%]) females. Among males mean ([SD]) age was 64.1 
([13.6]) yrs., and that of females was 62.8 ([13.8]) 
yrs.The age distribution was not uniform among 
different stroke etiologies. The mean age in unclassified 
stroke type ([more than one etiologies]) was 70 yrs. 
that was highest than the rest of stroke types, while the 
mean age in uncommon causes of stroke was 34 years 
that was significantly lower than the other stroke types. 
According to stroke etiology most of the patients were 
in supra aortic large artery atherosclerosis that totaled 
98 ([47.3%]) patients, followed by, Cardio embolism in 
40 ([19.3%]) patients, small artery occlusion in 22 
([10.6 %]) patients, cryptogenic type in 21 ([10.1 %]), 
unclassified in 20 ([9.7 %]),  and uncommon causes in 
5 ([2.4 %]), of patients. One patient had incomplete 
evaluation.
Stroke severity analysis:
When stroke severity was taken as mean NIHSS or as 
NIHSS categories ([mild, moderate or severe]), the 
results appeared similar (see Table 1 and figure 1). 
Higher number of patients were in moderate to severe 
category in cardio  embolic strokes ([mean NIHSS 
10.4]) and unclassified ([mean NIHSS 9.3]) stroke 
types. Small vessel occlusion type strokes had the 
lowest severity. When stroke severity ([mean NIHSS 
and/or NIHSS categories]) was compared with all 
variables other than stroke etiology, significant 
associations were found only with age and fasting 
triglyceride levels. Stroke severity was found to be 
higher with advancing age.  NIHSS scores were 
significantly lower with higher triglyceride levels and vice 
versa. ([see table 2 and figure 2]). When radiological 
features were compared to stroke severity ([Table 3]) it 
was found that higher stroke severity was associated 
with whole MCA territory / malignant MCA infarctions, 
while partial MCA infarctions were less severe. MRI DWI 
(Diffusion Weighted Imaging) assessment showed that 
large sized infarctions with more than 15 mm size 
([territorial, lobar or deep subcortical]) and those with 
hemorrhagic conversion, were more likely to be 
moderate or severe.
Sub category analysis ([stroke severity analysis by 
stroke etiology]):
We analyzed the relationship of different variables with 
stroke severity categories, in each stroke type / etiology. 
In this analysis  we found that only the Supra Aortic 
Large artery atherosclerosis and cryptogenic types 
([Table 4]) had the inverse relationship between stroke 
severity and triglyceride levels ([P = .04]). Apparently 
triglyceride levels did not produce similar effect on 
stroke severity in cardio aortic embolism and small 
vessel occlusion. In this sub category analysis, we also 
found that the pre-stroke anti platelet ([aspirin, 
clopidogrel or both]) and beta blocker use ([Table 5]) 
was significantly associated with lower stroke severity 
only in Supra Aortic Large artery atherosclerosis 
([P=.02]). In cardio aortic embolic strokes 10 patients 
were actively smoking out of which 6 patients suffered 
from severe stroke, 3 patients with moderate stroke 
and only one had mild stroke ([P=.03]).  
DISCUSSION:
In this exploratory study we compared many different 
characteristics of patients with acute ischemic stroke 
and analyzed them for their relationship with stroke 
severity. The stroke etiology / type, as is already known, 
was one of the main factors related to stroke severity 
([table 1]). The cardio aortic embolism and unclassified 
type (more than one etiology) were associated with 
more severe strokes, while supra aortic large artery 
atherosclerosis mostly with moderate severity and 
cryptogenic strokes, small artery occlusion, and 
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may give us clues to look for novel neuroprotection and 
possibly disease modifying strategies. We designed our 
research work as an exploratory study, aiming to 
observe relationships between  the clinical, laboratory 
and radiological features, and stroke severity among 
ischemic stroke patients. We identified clinical 
characteristics that are usually evaluated for nearly all 
hospitalized patients suffering ischemic stroke, and 
analyzed them for any significant relationship with 
stroke severity as measured by NIHSS. Given possibility 
of confounding factors and limitations of NIHSS we 
restricted our study only for ischemic strokes in middle 
cerebral artery ([MCA]) distribution.
 
METHODS:
This study was designed as an exploratory retrospective 
cross sectional survey. It was carried out in the 
department of Neurology, at Shifa International 
Hospital, Islamabad, Pakistan which is one of the 
largest tertiary care hospitals in the capital city.  The 
research protocol was approved by the Institutional 
Review Board of the same hospital. Only adult patients 
([18 years and above]) admitted in the neurology 
service, with the diagnosis of acute Middle Cerebral 
Artery (MCA) ischemic stroke (territorial or lacunar 
infarcts in MCA distribution), within three days of onset 
of ischemic symptoms over a period of 39 months 
([September 2009 to November 2012]) were 
considered. During the study period Intravenous tissue 
plasminogen activator, acute endovascular 
intervention, were not available in our hospital, 
therefore none of the patients received acute 
thrombolytic therapy. Patients with posterior circulation 
ischemia, having history of previous stroke, and those 
suffering from any disabling neurological disease other 
than stroke were excluded as the patients with previous 
strokes, and having a baseline neurological deficit may 
have a more severe deficit, because of the recurrent 
stroke, which may not be related to the more acute 
laboratory findings that we measured. The file records 
of selected patients were extracted and relevant clinical 
information pertaining to first 24 hours of hospital 
admissions was obtained. The laboratory values were 
taken from Hospital Information System (HIS), and 
radiological data was reviewed from Picture Archiving 
and Communication System ([PACS]) of the hospital. 
For etiological classification of stroke the online 
Causative Classification of Ischemic Stroke ([CSS]) 
System was used 4. The information thus obtained was 
entered in a predesigned data sheet. At the completion 
of the data collection all the data was entered in SPSS 
20. All the case histories, laboratory data in first 24 
hours of admission, and radiological information was 
reviewed and analyzed by a consultant neurologist and 
statisticians.
Operational definitions: 
1. Acute MCA ischemic stroke: An acute event that was 
diagnosed by the attending neurologist as ischemic 
stroke ([with or without hemorrhagic conversion]) and 
corresponds to areas supplied by middle cerebral artery 
and/ or its smaller perforator branches which was 
further radiologically confirmed by MRI ([DWI/ ADC 
sequences]) or CT scans.
2. Co- morbid hypertension: The file records showed 
that the patient was known to be hypertensive and he 
was on regular anti-hypertensive therapy, or was found 
to have a blood pressure of 160 mmHg / 90 mmHg or 
more on admission, that was not considered by the 
attending physician as transient rise due to cerebral 
compensating mechanisms.
3. Co- morbid diabetes: The file records showed 
that the patient was known to be diabetic and he/ she 
was taking regular anti diabetic medications, or his 
HbA1c was 6.5 % or more.
4. Co – morbid Ischemic heart disease and 
chronic renal failure: The patient was labelled to have 
above mentioned co-morbid conditions in the file 
records, diagnosed on the basis of clinical, 
electrocardiographic, biochemical, echocardiographic 
and ultra-sonographic investigations.
Categories by stroke etiology / stroke type:
We utilized the online software, CCS ([which is derived 
from TOAST classification]) to determine the stroke type 
by its etiology. 4 However we made some modifications 
in this classification system, so that statistical analyses 
were possible as some of the categories had very low 
number of patients.  In the original CCS classification 
there are 5 major categories and 4 subcategories. But, 
in our study we merged some of the subcategories and 
thus made in total 6 categories ([without any 
subcategories]) at the time of analyses of the data 
([table 1]). The subtype “unknown – cryptogenic 
embolism” and “unknown- other cryptogenic” in CCS 
were also combined together into cryptogenic type. The 
category “Unclassified” was used when more than one 
etiologies are identifiable in the same patient ([same as 
in original CCS classification]).  
Categories by stroke severity: 
Determined by NIHSS score. They were as follows5 ;
Mild: < 5, Moderate: 5- 14, Severe: ≥ 15 
V O L .  1 5  ( 2 )   A P R I L - J U N E  2 0 2 0
uncommon causes were associated with predominantly 
lower stroke severity. Similar results have been shown 
in other studies6,7. Furthermore the triglyceride levels 
were found to be inversely related to stroke severity, as 
the higher triglyceride levels were significantly 
associated with lower stroke severity and vice versa 
([table 2 and figure 2]). In fact, the role of higher serum 
triglycerides in reducing the stroke severity is a relatively 
novel concept, as hypertriglyceridemia is considered a 
risk factor for stroke. The association of triglyceride 
levels in blood, with stroke severity and outcome has 
emerged in a few other recently published studies8. 
Dziedzic et al., correlated the Scandinavian stroke scale 
([which is another measure of stroke severity])  to 
triglyceride levels, and concluded that lower triglyceride 
levels were associated with increased stroke severity9. 
A prospective study by Ryu etal, reported that higher 
fasting triglycerides on admission predict less disability, 
reduced disability progression, and all-cause mortality 
in patients with acute ischemic stroke10. Another study 
by Choi etal also confirmed that low serum triglyceride 
level is an independent predictor of mortality after 
ischemic stroke, but noted that this association did not 
hold true in the subgroup with cardioembolic stroke11. 
History of dyslipidemia was found to have a favorable 
effect on out come in ischemic stroke patients in Kyoto 
stroke registry12.  In one study higher cholesterol levels 
were also reported to be associated more frequently 
with minor strokes13. Our study elaborates this unusual 
phenomenon, as we further analyzed the distribution of 
triglycerides levels among different stroke severity 
categories in each stroke etiology/ type. What appeared 
in this later analysis is that the effect of serum 
triglyceride levels (as mentioned above) was significant 
only in supra aortic large artery atherosclerosis and 
cryptogenic types (table 4). The other types including 
cardioaortic embolic and small artery occlusion stroke 
types were not affected by triglyceride levels. The loss 
of this triglyceride effect in cardio aortic embolic strokes 
was also seen by  Choi etal ([see above])11. Current 
stroke pathophysiology models do not explain this 
phenomenon, as hypertriglyceridemia is actually 
considered a risk factor for stroke because of its long 
term effects on vascular endothelium. There can be 
many explanations for this associations. (1) Some 
authors consider serum triglycerides as an acute phase 
reactant that is decreased in severe strokes as a result 
of cerebral ischemia and perhaps may not actually have 
a direct protective effect against cerebral neuronal 
damage8. (2) Another likely possibility, though 
debatable, is the fact that high lipid containing plaque / 
clot is very likely to be friable, and thus embolise easily 
into more distal cerebral vasculature thus it may cause 
more incident stroke but that of lesser severity.(3) There 
is also a possibility that high lipids especially 
triglycerides, may have a more positive role in acute 
ischemic strokes.  It is a well-known fact that fats in 
general have a favorable effect on brain metabolism. 
For example; fatty diets like ketogenic diet is well known 
to have a therapeutic effect in refractory epilepsy in 
children, 14 although similar diet has not been 
thoroughly evaluated in adults with stroke or epilepsy. 
Thus more research is needed to elucidate the role of 
lipids/ triglycerides in during the acute phases of 
ischemic stroke. In supra aortic large artery 
atherosclerotic strokes pre stroke antiplatelet (aspirin, 
clopidogrel or both) and beta blocker use was 
significantly associated with lower stroke severity 
([table 5]). Aspirin use before stroke has been shown to 
have a beneficial effect in some other studies as similar 
findings were reported by Park etal 15 in 
atherothrombotic stroke. Same effect could not be 
seen in cardio aortic embolism and other stroke types 
16,17. The effect of beta blockers (propranolol and 
carvedilol) on brain ischemia has been shown in 
experimental models of stroke that suggest a 
neuroprotective effect on cerebral neurons18-20. 
Dziedzic T et al, found lower rates of early mortality after 
ischemic stroke in patients taking beta blockers, 
however, they did not report any effect on stroke 
severity22. They did not take stroke etiology into 
account, in their patients. Active current smoking was 
also found to be related to increased stroke severity in 
cardioembolic stroke but not in other types. Similar 
findings were reported by Edjoc etal.22 Among the 
radiological features, it was the size and not the site of 
the infarction that was mainly associated with stroke 
severity ([table 3]). In plain CT brain and MRI scans the 
whole MCA territory and malignant MCA infarctions had 
significantly higher stroke severity, while among the 
different MRI DWI patterns we found only the large ([> 
15 mm in size]) pattern irrespective of the location 
(lobar or deep subcortical) had significant association 
with severe strokes.
Weaknesses:
The study was a retrospective analysis with an 
exploratory design. We preferred such a study design 
because; (1) we were not testing any hypothesis, rather 
we aimed to look into possible novel strategies for 
neuroprotection that might generate newer 
studies.(2)The authors found it more feasible because 
of the limited resources at their disposal. Furthermore, 
a multivariate analysis could not be performed for 
specification of potential confounding effect and 
predictors of stroke severity due to design of study. 
Rather, we used restriction and stratification 
strategies in data selection and analysis to control for 
possible confounders. 
We also did not have the pre stroke or baseline 
triglyceride levels of our subjects, which was 
practically not possible either, therefore the theory of 
acute phase reaction to explain the inverse 




In spite of all the weaknesses we think that this study 
provides valuable information. Furthermore we 
analyzed our variables in different subsets and found 
that the relationship between stroke severity and 
triglyceride levels, pre-stroke anti platelet as well as 
beta blocker use and smoking, seemingly depends 
upon the etiological category of the stroke, a fact not 
particularly looked into as yet.
CONCLUSION:
Stroke severity is related to age and its etiology. There 
is also a possible inverse correlation between stroke 
severity and fasting triglyceride levels, which is seen 
predominantly in supra aortic large artery 
atherosclerotic and cryptogenic stroke etiologies. 
People who suffer ischemic strokes due to supra 
aortic large artery atherosclerosis, with pre-stroke use 
of anti-platelets and beta blockers, also seem to have 
a reduced stroke severity. Furthermore, patients who 
actively smoke may have more severe strokes, if they 
have a cardio embolic etiology. We would recommend 
future studies to verify if factors we found have a 
consistent causal association, in the context of 
different stroke etiologies.  
Table 1: stroke severity by categories vs stroke 
etiology.
*Shows statistically significant proportion of severity 
of stroke with stroke types (P<.001)
Figure 1 : Mean NIHSS score Difference 
according to stroke etiology
Bar graph showing significant mean NIHSS score 
associated with stroke sub-types ([F= 6.317, 
P=.001]). Cardio aortic embolic strokes and 
unclassified strokes had the highest severity. 
Table 2 : stroke severity as compared to different 
variables:
Figure 2 : Scatter plot showing inverse relationship 
between NIHSS at admission and triglyceride 
levels
Table 3 : Radiological features vs stroke severity
*significant values.
Table 4 : Mean Triglyceride levels in different 
stroke categories
Table 5: impact of pre-stroke medicines and stroke 
severity
a Statistical significance using Pearson’s chi-square 
test b Fischer’s exact test.
Statistical analysis:
Data analysis was done by using SPSS version-20.0 
([IBM Product-USA]). The categorical response 
variables included patient’s demographic features, 
etiology of stroke, co- morbid conditions, family history, 
clinical features and severity of stroke. The numeric 
response variables like fasting triglyceride and other 
lipid levels, HbA1c, random blood sugar ([RBS]), 
Systolic Blood Pressure, and fasting lipid profile were 
presented as mean (standard deviation). Analysis of 
variance ([ANOVA]) was performed to compare these 
numeric response variables. Later, these numeric 
variables were stratified in order to control the 
confounding effect and effect modifiers. Stroke severity 
was also stratified into three categories i.e., mild, 
moderate and severe. Bivariate analysis by using 
Chi-square test was done to see relationship of 
aforementioned variables with the severity of stroke 
measured by NIHSS and divided into categories. 
Pearson’s correlation coefficient was calculated to see 
the relationship of triglyceride level with the NIHSS. 
P-value ≤.05 was considered statistically significant 
result.
RESULTS:
Baseline characteristics of patients:
Total 207 patients were selected after applying the 
inclusion and exclusion criteria. The mean ([SD]) age of 
patients was 63.5 ([13.7]) yrs. ([range 26 yrs. – 95 
yrs.]). There were 117 ([56.5 %]) males and 90 ([43.5 
%]) females. Among males mean ([SD]) age was 64.1 
([13.6]) yrs., and that of females was 62.8 ([13.8]) 
yrs.The age distribution was not uniform among 
different stroke etiologies. The mean age in unclassified 
stroke type ([more than one etiologies]) was 70 yrs. 
that was highest than the rest of stroke types, while the 
mean age in uncommon causes of stroke was 34 years 
that was significantly lower than the other stroke types. 
According to stroke etiology most of the patients were 
in supra aortic large artery atherosclerosis that totaled 
98 ([47.3%]) patients, followed by, Cardio embolism in 
40 ([19.3%]) patients, small artery occlusion in 22 
([10.6 %]) patients, cryptogenic type in 21 ([10.1 %]), 
unclassified in 20 ([9.7 %]),  and uncommon causes in 
5 ([2.4 %]), of patients. One patient had incomplete 
evaluation.
Stroke severity analysis:
When stroke severity was taken as mean NIHSS or as 
NIHSS categories ([mild, moderate or severe]), the 
results appeared similar (see Table 1 and figure 1). 
Higher number of patients were in moderate to severe 
category in cardio  embolic strokes ([mean NIHSS 
10.4]) and unclassified ([mean NIHSS 9.3]) stroke 
types. Small vessel occlusion type strokes had the 
lowest severity. When stroke severity ([mean NIHSS 
and/or NIHSS categories]) was compared with all 
variables other than stroke etiology, significant 
associations were found only with age and fasting 
triglyceride levels. Stroke severity was found to be 
higher with advancing age.  NIHSS scores were 
significantly lower with higher triglyceride levels and vice 
versa. ([see table 2 and figure 2]). When radiological 
features were compared to stroke severity ([Table 3]) it 
was found that higher stroke severity was associated 
with whole MCA territory / malignant MCA infarctions, 
while partial MCA infarctions were less severe. MRI DWI 
(Diffusion Weighted Imaging) assessment showed that 
large sized infarctions with more than 15 mm size 
([territorial, lobar or deep subcortical]) and those with 
hemorrhagic conversion, were more likely to be 
moderate or severe.
Sub category analysis ([stroke severity analysis by 
stroke etiology]):
We analyzed the relationship of different variables with 
stroke severity categories, in each stroke type / etiology. 
In this analysis  we found that only the Supra Aortic 
Large artery atherosclerosis and cryptogenic types 
([Table 4]) had the inverse relationship between stroke 
severity and triglyceride levels ([P = .04]). Apparently 
triglyceride levels did not produce similar effect on 
stroke severity in cardio aortic embolism and small 
vessel occlusion. In this sub category analysis, we also 
found that the pre-stroke anti platelet ([aspirin, 
clopidogrel or both]) and beta blocker use ([Table 5]) 
was significantly associated with lower stroke severity 
only in Supra Aortic Large artery atherosclerosis 
([P=.02]). In cardio aortic embolic strokes 10 patients 
were actively smoking out of which 6 patients suffered 
from severe stroke, 3 patients with moderate stroke 
and only one had mild stroke ([P=.03]).  
DISCUSSION:
In this exploratory study we compared many different 
characteristics of patients with acute ischemic stroke 
and analyzed them for their relationship with stroke 
severity. The stroke etiology / type, as is already known, 
was one of the main factors related to stroke severity 
([table 1]). The cardio aortic embolism and unclassified 
type (more than one etiology) were associated with 
more severe strokes, while supra aortic large artery 
atherosclerosis mostly with moderate severity and 
cryptogenic strokes, small artery occlusion, and 
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may give us clues to look for novel neuroprotection and 
possibly disease modifying strategies. We designed our 
research work as an exploratory study, aiming to 
observe relationships between  the clinical, laboratory 
and radiological features, and stroke severity among 
ischemic stroke patients. We identified clinical 
characteristics that are usually evaluated for nearly all 
hospitalized patients suffering ischemic stroke, and 
analyzed them for any significant relationship with 
stroke severity as measured by NIHSS. Given possibility 
of confounding factors and limitations of NIHSS we 
restricted our study only for ischemic strokes in middle 
cerebral artery ([MCA]) distribution.
 
METHODS:
This study was designed as an exploratory retrospective 
cross sectional survey. It was carried out in the 
department of Neurology, at Shifa International 
Hospital, Islamabad, Pakistan which is one of the 
largest tertiary care hospitals in the capital city.  The 
research protocol was approved by the Institutional 
Review Board of the same hospital. Only adult patients 
([18 years and above]) admitted in the neurology 
service, with the diagnosis of acute Middle Cerebral 
Artery (MCA) ischemic stroke (territorial or lacunar 
infarcts in MCA distribution), within three days of onset 
of ischemic symptoms over a period of 39 months 
([September 2009 to November 2012]) were 
considered. During the study period Intravenous tissue 
plasminogen activator, acute endovascular 
intervention, were not available in our hospital, 
therefore none of the patients received acute 
thrombolytic therapy. Patients with posterior circulation 
ischemia, having history of previous stroke, and those 
suffering from any disabling neurological disease other 
than stroke were excluded as the patients with previous 
strokes, and having a baseline neurological deficit may 
have a more severe deficit, because of the recurrent 
stroke, which may not be related to the more acute 
laboratory findings that we measured. The file records 
of selected patients were extracted and relevant clinical 
information pertaining to first 24 hours of hospital 
admissions was obtained. The laboratory values were 
taken from Hospital Information System (HIS), and 
radiological data was reviewed from Picture Archiving 
and Communication System ([PACS]) of the hospital. 
For etiological classification of stroke the online 
Causative Classification of Ischemic Stroke ([CSS]) 
System was used 4. The information thus obtained was 
entered in a predesigned data sheet. At the completion 
of the data collection all the data was entered in SPSS 
20. All the case histories, laboratory data in first 24 
hours of admission, and radiological information was 
reviewed and analyzed by a consultant neurologist and 
statisticians.
Operational definitions: 
1. Acute MCA ischemic stroke: An acute event that was 
diagnosed by the attending neurologist as ischemic 
stroke ([with or without hemorrhagic conversion]) and 
corresponds to areas supplied by middle cerebral artery 
and/ or its smaller perforator branches which was 
further radiologically confirmed by MRI ([DWI/ ADC 
sequences]) or CT scans.
2. Co- morbid hypertension: The file records showed 
that the patient was known to be hypertensive and he 
was on regular anti-hypertensive therapy, or was found 
to have a blood pressure of 160 mmHg / 90 mmHg or 
more on admission, that was not considered by the 
attending physician as transient rise due to cerebral 
compensating mechanisms.
3. Co- morbid diabetes: The file records showed 
that the patient was known to be diabetic and he/ she 
was taking regular anti diabetic medications, or his 
HbA1c was 6.5 % or more.
4. Co – morbid Ischemic heart disease and 
chronic renal failure: The patient was labelled to have 
above mentioned co-morbid conditions in the file 
records, diagnosed on the basis of clinical, 
electrocardiographic, biochemical, echocardiographic 
and ultra-sonographic investigations.
Categories by stroke etiology / stroke type:
We utilized the online software, CCS ([which is derived 
from TOAST classification]) to determine the stroke type 
by its etiology. 4 However we made some modifications 
in this classification system, so that statistical analyses 
were possible as some of the categories had very low 
number of patients.  In the original CCS classification 
there are 5 major categories and 4 subcategories. But, 
in our study we merged some of the subcategories and 
thus made in total 6 categories ([without any 
subcategories]) at the time of analyses of the data 
([table 1]). The subtype “unknown – cryptogenic 
embolism” and “unknown- other cryptogenic” in CCS 
were also combined together into cryptogenic type. The 
category “Unclassified” was used when more than one 
etiologies are identifiable in the same patient ([same as 
in original CCS classification]).  
Categories by stroke severity: 
Determined by NIHSS score. They were as follows5 ;
Mild: < 5, Moderate: 5- 14, Severe: ≥ 15 
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uncommon causes were associated with predominantly 
lower stroke severity. Similar results have been shown 
in other studies6,7. Furthermore the triglyceride levels 
were found to be inversely related to stroke severity, as 
the higher triglyceride levels were significantly 
associated with lower stroke severity and vice versa 
([table 2 and figure 2]). In fact, the role of higher serum 
triglycerides in reducing the stroke severity is a relatively 
novel concept, as hypertriglyceridemia is considered a 
risk factor for stroke. The association of triglyceride 
levels in blood, with stroke severity and outcome has 
emerged in a few other recently published studies8. 
Dziedzic et al., correlated the Scandinavian stroke scale 
([which is another measure of stroke severity])  to 
triglyceride levels, and concluded that lower triglyceride 
levels were associated with increased stroke severity9. 
A prospective study by Ryu etal, reported that higher 
fasting triglycerides on admission predict less disability, 
reduced disability progression, and all-cause mortality 
in patients with acute ischemic stroke10. Another study 
by Choi etal also confirmed that low serum triglyceride 
level is an independent predictor of mortality after 
ischemic stroke, but noted that this association did not 
hold true in the subgroup with cardioembolic stroke11. 
History of dyslipidemia was found to have a favorable 
effect on out come in ischemic stroke patients in Kyoto 
stroke registry12.  In one study higher cholesterol levels 
were also reported to be associated more frequently 
with minor strokes13. Our study elaborates this unusual 
phenomenon, as we further analyzed the distribution of 
triglycerides levels among different stroke severity 
categories in each stroke etiology/ type. What appeared 
in this later analysis is that the effect of serum 
triglyceride levels (as mentioned above) was significant 
only in supra aortic large artery atherosclerosis and 
cryptogenic types (table 4). The other types including 
cardioaortic embolic and small artery occlusion stroke 
types were not affected by triglyceride levels. The loss 
of this triglyceride effect in cardio aortic embolic strokes 
was also seen by  Choi etal ([see above])11. Current 
stroke pathophysiology models do not explain this 
phenomenon, as hypertriglyceridemia is actually 
considered a risk factor for stroke because of its long 
term effects on vascular endothelium. There can be 
many explanations for this associations. (1) Some 
authors consider serum triglycerides as an acute phase 
reactant that is decreased in severe strokes as a result 
of cerebral ischemia and perhaps may not actually have 
a direct protective effect against cerebral neuronal 
damage8. (2) Another likely possibility, though 
debatable, is the fact that high lipid containing plaque / 
clot is very likely to be friable, and thus embolise easily 
into more distal cerebral vasculature thus it may cause 
more incident stroke but that of lesser severity.(3) There 
is also a possibility that high lipids especially 
triglycerides, may have a more positive role in acute 
ischemic strokes.  It is a well-known fact that fats in 
general have a favorable effect on brain metabolism. 
For example; fatty diets like ketogenic diet is well known 
to have a therapeutic effect in refractory epilepsy in 
children, 14 although similar diet has not been 
thoroughly evaluated in adults with stroke or epilepsy. 
Thus more research is needed to elucidate the role of 
lipids/ triglycerides in during the acute phases of 
ischemic stroke. In supra aortic large artery 
atherosclerotic strokes pre stroke antiplatelet (aspirin, 
clopidogrel or both) and beta blocker use was 
significantly associated with lower stroke severity 
([table 5]). Aspirin use before stroke has been shown to 
have a beneficial effect in some other studies as similar 
findings were reported by Park etal 15 in 
atherothrombotic stroke. Same effect could not be 
seen in cardio aortic embolism and other stroke types 
16,17. The effect of beta blockers (propranolol and 
carvedilol) on brain ischemia has been shown in 
experimental models of stroke that suggest a 
neuroprotective effect on cerebral neurons18-20. 
Dziedzic T et al, found lower rates of early mortality after 
ischemic stroke in patients taking beta blockers, 
however, they did not report any effect on stroke 
severity22. They did not take stroke etiology into 
account, in their patients. Active current smoking was 
also found to be related to increased stroke severity in 
cardioembolic stroke but not in other types. Similar 
findings were reported by Edjoc etal.22 Among the 
radiological features, it was the size and not the site of 
the infarction that was mainly associated with stroke 
severity ([table 3]). In plain CT brain and MRI scans the 
whole MCA territory and malignant MCA infarctions had 
significantly higher stroke severity, while among the 
different MRI DWI patterns we found only the large ([> 
15 mm in size]) pattern irrespective of the location 
(lobar or deep subcortical) had significant association 
with severe strokes.
Weaknesses:
The study was a retrospective analysis with an 
exploratory design. We preferred such a study design 
because; (1) we were not testing any hypothesis, rather 
we aimed to look into possible novel strategies for 
neuroprotection that might generate newer 
studies.(2)The authors found it more feasible because 
of the limited resources at their disposal. Furthermore, 
a multivariate analysis could not be performed for 
specification of potential confounding effect and 
predictors of stroke severity due to design of study. 
Rather, we used restriction and stratification 
strategies in data selection and analysis to control for 
possible confounders. 
We also did not have the pre stroke or baseline 
triglyceride levels of our subjects, which was 
practically not possible either, therefore the theory of 
acute phase reaction to explain the inverse 




In spite of all the weaknesses we think that this study 
provides valuable information. Furthermore we 
analyzed our variables in different subsets and found 
that the relationship between stroke severity and 
triglyceride levels, pre-stroke anti platelet as well as 
beta blocker use and smoking, seemingly depends 
upon the etiological category of the stroke, a fact not 
particularly looked into as yet.
CONCLUSION:
Stroke severity is related to age and its etiology. There 
is also a possible inverse correlation between stroke 
severity and fasting triglyceride levels, which is seen 
predominantly in supra aortic large artery 
atherosclerotic and cryptogenic stroke etiologies. 
People who suffer ischemic strokes due to supra 
aortic large artery atherosclerosis, with pre-stroke use 
of anti-platelets and beta blockers, also seem to have 
a reduced stroke severity. Furthermore, patients who 
actively smoke may have more severe strokes, if they 
have a cardio embolic etiology. We would recommend 
future studies to verify if factors we found have a 
consistent causal association, in the context of 
different stroke etiologies.  
Table 1: stroke severity by categories vs stroke 
etiology.
*Shows statistically significant proportion of severity 
of stroke with stroke types (P<.001)
Figure 1 : Mean NIHSS score Difference 
according to stroke etiology
Bar graph showing significant mean NIHSS score 
associated with stroke sub-types ([F= 6.317, 
P=.001]). Cardio aortic embolic strokes and 
unclassified strokes had the highest severity. 
Table 2 : stroke severity as compared to different 
variables:
Figure 2 : Scatter plot showing inverse relationship 
between NIHSS at admission and triglyceride 
levels
Table 3 : Radiological features vs stroke severity
*significant values.
Table 4 : Mean Triglyceride levels in different 
stroke categories
Table 5: impact of pre-stroke medicines and stroke 
severity
a Statistical significance using Pearson’s chi-square 
test b Fischer’s exact test.
Statistical analysis:
Data analysis was done by using SPSS version-20.0 
([IBM Product-USA]). The categorical response 
variables included patient’s demographic features, 
etiology of stroke, co- morbid conditions, family history, 
clinical features and severity of stroke. The numeric 
response variables like fasting triglyceride and other 
lipid levels, HbA1c, random blood sugar ([RBS]), 
Systolic Blood Pressure, and fasting lipid profile were 
presented as mean (standard deviation). Analysis of 
variance ([ANOVA]) was performed to compare these 
numeric response variables. Later, these numeric 
variables were stratified in order to control the 
confounding effect and effect modifiers. Stroke severity 
was also stratified into three categories i.e., mild, 
moderate and severe. Bivariate analysis by using 
Chi-square test was done to see relationship of 
aforementioned variables with the severity of stroke 
measured by NIHSS and divided into categories. 
Pearson’s correlation coefficient was calculated to see 
the relationship of triglyceride level with the NIHSS. 
P-value ≤.05 was considered statistically significant 
result.
RESULTS:
Baseline characteristics of patients:
Total 207 patients were selected after applying the 
inclusion and exclusion criteria. The mean ([SD]) age of 
patients was 63.5 ([13.7]) yrs. ([range 26 yrs. – 95 
yrs.]). There were 117 ([56.5 %]) males and 90 ([43.5 
%]) females. Among males mean ([SD]) age was 64.1 
([13.6]) yrs., and that of females was 62.8 ([13.8]) 
yrs.The age distribution was not uniform among 
different stroke etiologies. The mean age in unclassified 
stroke type ([more than one etiologies]) was 70 yrs. 
that was highest than the rest of stroke types, while the 
mean age in uncommon causes of stroke was 34 years 
that was significantly lower than the other stroke types. 
According to stroke etiology most of the patients were 
in supra aortic large artery atherosclerosis that totaled 
98 ([47.3%]) patients, followed by, Cardio embolism in 
40 ([19.3%]) patients, small artery occlusion in 22 
([10.6 %]) patients, cryptogenic type in 21 ([10.1 %]), 
unclassified in 20 ([9.7 %]),  and uncommon causes in 
5 ([2.4 %]), of patients. One patient had incomplete 
evaluation.
Stroke severity analysis:
When stroke severity was taken as mean NIHSS or as 
NIHSS categories ([mild, moderate or severe]), the 
results appeared similar (see Table 1 and figure 1). 
Higher number of patients were in moderate to severe 
category in cardio  embolic strokes ([mean NIHSS 
10.4]) and unclassified ([mean NIHSS 9.3]) stroke 
types. Small vessel occlusion type strokes had the 
lowest severity. When stroke severity ([mean NIHSS 
and/or NIHSS categories]) was compared with all 
variables other than stroke etiology, significant 
associations were found only with age and fasting 
triglyceride levels. Stroke severity was found to be 
higher with advancing age.  NIHSS scores were 
significantly lower with higher triglyceride levels and vice 
versa. ([see table 2 and figure 2]). When radiological 
features were compared to stroke severity ([Table 3]) it 
was found that higher stroke severity was associated 
with whole MCA territory / malignant MCA infarctions, 
while partial MCA infarctions were less severe. MRI DWI 
(Diffusion Weighted Imaging) assessment showed that 
large sized infarctions with more than 15 mm size 
([territorial, lobar or deep subcortical]) and those with 
hemorrhagic conversion, were more likely to be 
moderate or severe.
Sub category analysis ([stroke severity analysis by 
stroke etiology]):
We analyzed the relationship of different variables with 
stroke severity categories, in each stroke type / etiology. 
In this analysis  we found that only the Supra Aortic 
Large artery atherosclerosis and cryptogenic types 
([Table 4]) had the inverse relationship between stroke 
severity and triglyceride levels ([P = .04]). Apparently 
triglyceride levels did not produce similar effect on 
stroke severity in cardio aortic embolism and small 
vessel occlusion. In this sub category analysis, we also 
found that the pre-stroke anti platelet ([aspirin, 
clopidogrel or both]) and beta blocker use ([Table 5]) 
was significantly associated with lower stroke severity 
only in Supra Aortic Large artery atherosclerosis 
([P=.02]). In cardio aortic embolic strokes 10 patients 
were actively smoking out of which 6 patients suffered 
from severe stroke, 3 patients with moderate stroke 
and only one had mild stroke ([P=.03]).  
DISCUSSION:
In this exploratory study we compared many different 
characteristics of patients with acute ischemic stroke 
and analyzed them for their relationship with stroke 
severity. The stroke etiology / type, as is already known, 
was one of the main factors related to stroke severity 
([table 1]). The cardio aortic embolism and unclassified 
type (more than one etiology) were associated with 
more severe strokes, while supra aortic large artery 
atherosclerosis mostly with moderate severity and 
cryptogenic strokes, small artery occlusion, and 
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may give us clues to look for novel neuroprotection and 
possibly disease modifying strategies. We designed our 
research work as an exploratory study, aiming to 
observe relationships between  the clinical, laboratory 
and radiological features, and stroke severity among 
ischemic stroke patients. We identified clinical 
characteristics that are usually evaluated for nearly all 
hospitalized patients suffering ischemic stroke, and 
analyzed them for any significant relationship with 
stroke severity as measured by NIHSS. Given possibility 
of confounding factors and limitations of NIHSS we 
restricted our study only for ischemic strokes in middle 
cerebral artery ([MCA]) distribution.
 
METHODS:
This study was designed as an exploratory retrospective 
cross sectional survey. It was carried out in the 
department of Neurology, at Shifa International 
Hospital, Islamabad, Pakistan which is one of the 
largest tertiary care hospitals in the capital city.  The 
research protocol was approved by the Institutional 
Review Board of the same hospital. Only adult patients 
([18 years and above]) admitted in the neurology 
service, with the diagnosis of acute Middle Cerebral 
Artery (MCA) ischemic stroke (territorial or lacunar 
infarcts in MCA distribution), within three days of onset 
of ischemic symptoms over a period of 39 months 
([September 2009 to November 2012]) were 
considered. During the study period Intravenous tissue 
plasminogen activator, acute endovascular 
intervention, were not available in our hospital, 
therefore none of the patients received acute 
thrombolytic therapy. Patients with posterior circulation 
ischemia, having history of previous stroke, and those 
suffering from any disabling neurological disease other 
than stroke were excluded as the patients with previous 
strokes, and having a baseline neurological deficit may 
have a more severe deficit, because of the recurrent 
stroke, which may not be related to the more acute 
laboratory findings that we measured. The file records 
of selected patients were extracted and relevant clinical 
information pertaining to first 24 hours of hospital 
admissions was obtained. The laboratory values were 
taken from Hospital Information System (HIS), and 
radiological data was reviewed from Picture Archiving 
and Communication System ([PACS]) of the hospital. 
For etiological classification of stroke the online 
Causative Classification of Ischemic Stroke ([CSS]) 
System was used 4. The information thus obtained was 
entered in a predesigned data sheet. At the completion 
of the data collection all the data was entered in SPSS 
20. All the case histories, laboratory data in first 24 
hours of admission, and radiological information was 
reviewed and analyzed by a consultant neurologist and 
statisticians.
Operational definitions: 
1. Acute MCA ischemic stroke: An acute event that was 
diagnosed by the attending neurologist as ischemic 
stroke ([with or without hemorrhagic conversion]) and 
corresponds to areas supplied by middle cerebral artery 
and/ or its smaller perforator branches which was 
further radiologically confirmed by MRI ([DWI/ ADC 
sequences]) or CT scans.
2. Co- morbid hypertension: The file records showed 
that the patient was known to be hypertensive and he 
was on regular anti-hypertensive therapy, or was found 
to have a blood pressure of 160 mmHg / 90 mmHg or 
more on admission, that was not considered by the 
attending physician as transient rise due to cerebral 
compensating mechanisms.
3. Co- morbid diabetes: The file records showed 
that the patient was known to be diabetic and he/ she 
was taking regular anti diabetic medications, or his 
HbA1c was 6.5 % or more.
4. Co – morbid Ischemic heart disease and 
chronic renal failure: The patient was labelled to have 
above mentioned co-morbid conditions in the file 
records, diagnosed on the basis of clinical, 
electrocardiographic, biochemical, echocardiographic 
and ultra-sonographic investigations.
Categories by stroke etiology / stroke type:
We utilized the online software, CCS ([which is derived 
from TOAST classification]) to determine the stroke type 
by its etiology. 4 However we made some modifications 
in this classification system, so that statistical analyses 
were possible as some of the categories had very low 
number of patients.  In the original CCS classification 
there are 5 major categories and 4 subcategories. But, 
in our study we merged some of the subcategories and 
thus made in total 6 categories ([without any 
subcategories]) at the time of analyses of the data 
([table 1]). The subtype “unknown – cryptogenic 
embolism” and “unknown- other cryptogenic” in CCS 
were also combined together into cryptogenic type. The 
category “Unclassified” was used when more than one 
etiologies are identifiable in the same patient ([same as 
in original CCS classification]).  
Categories by stroke severity: 
Determined by NIHSS score. They were as follows5 ;
Mild: < 5, Moderate: 5- 14, Severe: ≥ 15 
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uncommon causes were associated with predominantly 
lower stroke severity. Similar results have been shown 
in other studies6,7. Furthermore the triglyceride levels 
were found to be inversely related to stroke severity, as 
the higher triglyceride levels were significantly 
associated with lower stroke severity and vice versa 
([table 2 and figure 2]). In fact, the role of higher serum 
triglycerides in reducing the stroke severity is a relatively 
novel concept, as hypertriglyceridemia is considered a 
risk factor for stroke. The association of triglyceride 
levels in blood, with stroke severity and outcome has 
emerged in a few other recently published studies8. 
Dziedzic et al., correlated the Scandinavian stroke scale 
([which is another measure of stroke severity])  to 
triglyceride levels, and concluded that lower triglyceride 
levels were associated with increased stroke severity9. 
A prospective study by Ryu etal, reported that higher 
fasting triglycerides on admission predict less disability, 
reduced disability progression, and all-cause mortality 
in patients with acute ischemic stroke10. Another study 
by Choi etal also confirmed that low serum triglyceride 
level is an independent predictor of mortality after 
ischemic stroke, but noted that this association did not 
hold true in the subgroup with cardioembolic stroke11. 
History of dyslipidemia was found to have a favorable 
effect on out come in ischemic stroke patients in Kyoto 
stroke registry12.  In one study higher cholesterol levels 
were also reported to be associated more frequently 
with minor strokes13. Our study elaborates this unusual 
phenomenon, as we further analyzed the distribution of 
triglycerides levels among different stroke severity 
categories in each stroke etiology/ type. What appeared 
in this later analysis is that the effect of serum 
triglyceride levels (as mentioned above) was significant 
only in supra aortic large artery atherosclerosis and 
cryptogenic types (table 4). The other types including 
cardioaortic embolic and small artery occlusion stroke 
types were not affected by triglyceride levels. The loss 
of this triglyceride effect in cardio aortic embolic strokes 
was also seen by  Choi etal ([see above])11. Current 
stroke pathophysiology models do not explain this 
phenomenon, as hypertriglyceridemia is actually 
considered a risk factor for stroke because of its long 
term effects on vascular endothelium. There can be 
many explanations for this associations. (1) Some 
authors consider serum triglycerides as an acute phase 
reactant that is decreased in severe strokes as a result 
of cerebral ischemia and perhaps may not actually have 
a direct protective effect against cerebral neuronal 
damage8. (2) Another likely possibility, though 
debatable, is the fact that high lipid containing plaque / 
clot is very likely to be friable, and thus embolise easily 
into more distal cerebral vasculature thus it may cause 
more incident stroke but that of lesser severity.(3) There 
is also a possibility that high lipids especially 
triglycerides, may have a more positive role in acute 
ischemic strokes.  It is a well-known fact that fats in 
general have a favorable effect on brain metabolism. 
For example; fatty diets like ketogenic diet is well known 
to have a therapeutic effect in refractory epilepsy in 
children, 14 although similar diet has not been 
thoroughly evaluated in adults with stroke or epilepsy. 
Thus more research is needed to elucidate the role of 
lipids/ triglycerides in during the acute phases of 
ischemic stroke. In supra aortic large artery 
atherosclerotic strokes pre stroke antiplatelet (aspirin, 
clopidogrel or both) and beta blocker use was 
significantly associated with lower stroke severity 
([table 5]). Aspirin use before stroke has been shown to 
have a beneficial effect in some other studies as similar 
findings were reported by Park etal 15 in 
atherothrombotic stroke. Same effect could not be 
seen in cardio aortic embolism and other stroke types 
16,17. The effect of beta blockers (propranolol and 
carvedilol) on brain ischemia has been shown in 
experimental models of stroke that suggest a 
neuroprotective effect on cerebral neurons18-20. 
Dziedzic T et al, found lower rates of early mortality after 
ischemic stroke in patients taking beta blockers, 
however, they did not report any effect on stroke 
severity22. They did not take stroke etiology into 
account, in their patients. Active current smoking was 
also found to be related to increased stroke severity in 
cardioembolic stroke but not in other types. Similar 
findings were reported by Edjoc etal.22 Among the 
radiological features, it was the size and not the site of 
the infarction that was mainly associated with stroke 
severity ([table 3]). In plain CT brain and MRI scans the 
whole MCA territory and malignant MCA infarctions had 
significantly higher stroke severity, while among the 
different MRI DWI patterns we found only the large ([> 
15 mm in size]) pattern irrespective of the location 
(lobar or deep subcortical) had significant association 
with severe strokes.
Weaknesses:
The study was a retrospective analysis with an 
exploratory design. We preferred such a study design 
because; (1) we were not testing any hypothesis, rather 
we aimed to look into possible novel strategies for 
neuroprotection that might generate newer 
studies.(2)The authors found it more feasible because 
of the limited resources at their disposal. Furthermore, 
a multivariate analysis could not be performed for 
specification of potential confounding effect and 
predictors of stroke severity due to design of study. 
Rather, we used restriction and stratification 
strategies in data selection and analysis to control for 
possible confounders. 
We also did not have the pre stroke or baseline 
triglyceride levels of our subjects, which was 
practically not possible either, therefore the theory of 
acute phase reaction to explain the inverse 




In spite of all the weaknesses we think that this study 
provides valuable information. Furthermore we 
analyzed our variables in different subsets and found 
that the relationship between stroke severity and 
triglyceride levels, pre-stroke anti platelet as well as 
beta blocker use and smoking, seemingly depends 
upon the etiological category of the stroke, a fact not 
particularly looked into as yet.
CONCLUSION:
Stroke severity is related to age and its etiology. There 
is also a possible inverse correlation between stroke 
severity and fasting triglyceride levels, which is seen 
predominantly in supra aortic large artery 
atherosclerotic and cryptogenic stroke etiologies. 
People who suffer ischemic strokes due to supra 
aortic large artery atherosclerosis, with pre-stroke use 
of anti-platelets and beta blockers, also seem to have 
a reduced stroke severity. Furthermore, patients who 
actively smoke may have more severe strokes, if they 
have a cardio embolic etiology. We would recommend 
future studies to verify if factors we found have a 
consistent causal association, in the context of 
different stroke etiologies.  
Table 1: stroke severity by categories vs stroke 
etiology.
*Shows statistically significant proportion of severity 
of stroke with stroke types (P<.001)
Figure 1 : Mean NIHSS score Difference 
according to stroke etiology
Bar graph showing significant mean NIHSS score 
associated with stroke sub-types ([F= 6.317, 
P=.001]). Cardio aortic embolic strokes and 
unclassified strokes had the highest severity. 
Table 2 : stroke severity as compared to different 
variables:
Figure 2 : Scatter plot showing inverse relationship 
between NIHSS at admission and triglyceride 
levels
Table 3 : Radiological features vs stroke severity
*significant values.
Table 4 : Mean Triglyceride levels in different 
stroke categories
Table 5: impact of pre-stroke medicines and stroke 
severity
a Statistical significance using Pearson’s chi-square 
test b Fischer’s exact test.
Statistical analysis:
Data analysis was done by using SPSS version-20.0 
([IBM Product-USA]). The categorical response 
variables included patient’s demographic features, 
etiology of stroke, co- morbid conditions, family history, 
clinical features and severity of stroke. The numeric 
response variables like fasting triglyceride and other 
lipid levels, HbA1c, random blood sugar ([RBS]), 
Systolic Blood Pressure, and fasting lipid profile were 
presented as mean (standard deviation). Analysis of 
variance ([ANOVA]) was performed to compare these 
numeric response variables. Later, these numeric 
variables were stratified in order to control the 
confounding effect and effect modifiers. Stroke severity 
was also stratified into three categories i.e., mild, 
moderate and severe. Bivariate analysis by using 
Chi-square test was done to see relationship of 
aforementioned variables with the severity of stroke 
measured by NIHSS and divided into categories. 
Pearson’s correlation coefficient was calculated to see 
the relationship of triglyceride level with the NIHSS. 
P-value ≤.05 was considered statistically significant 
result.
RESULTS:
Baseline characteristics of patients:
Total 207 patients were selected after applying the 
inclusion and exclusion criteria. The mean ([SD]) age of 
patients was 63.5 ([13.7]) yrs. ([range 26 yrs. – 95 
yrs.]). There were 117 ([56.5 %]) males and 90 ([43.5 
%]) females. Among males mean ([SD]) age was 64.1 
([13.6]) yrs., and that of females was 62.8 ([13.8]) 
yrs.The age distribution was not uniform among 
different stroke etiologies. The mean age in unclassified 
stroke type ([more than one etiologies]) was 70 yrs. 
that was highest than the rest of stroke types, while the 
mean age in uncommon causes of stroke was 34 years 
that was significantly lower than the other stroke types. 
According to stroke etiology most of the patients were 
in supra aortic large artery atherosclerosis that totaled 
98 ([47.3%]) patients, followed by, Cardio embolism in 
40 ([19.3%]) patients, small artery occlusion in 22 
([10.6 %]) patients, cryptogenic type in 21 ([10.1 %]), 
unclassified in 20 ([9.7 %]),  and uncommon causes in 
5 ([2.4 %]), of patients. One patient had incomplete 
evaluation.
Stroke severity analysis:
When stroke severity was taken as mean NIHSS or as 
NIHSS categories ([mild, moderate or severe]), the 
results appeared similar (see Table 1 and figure 1). 
Higher number of patients were in moderate to severe 
category in cardio  embolic strokes ([mean NIHSS 
10.4]) and unclassified ([mean NIHSS 9.3]) stroke 
types. Small vessel occlusion type strokes had the 
lowest severity. When stroke severity ([mean NIHSS 
and/or NIHSS categories]) was compared with all 
variables other than stroke etiology, significant 
associations were found only with age and fasting 
triglyceride levels. Stroke severity was found to be 
higher with advancing age.  NIHSS scores were 
significantly lower with higher triglyceride levels and vice 
versa. ([see table 2 and figure 2]). When radiological 
features were compared to stroke severity ([Table 3]) it 
was found that higher stroke severity was associated 
with whole MCA territory / malignant MCA infarctions, 
while partial MCA infarctions were less severe. MRI DWI 
(Diffusion Weighted Imaging) assessment showed that 
large sized infarctions with more than 15 mm size 
([territorial, lobar or deep subcortical]) and those with 
hemorrhagic conversion, were more likely to be 
moderate or severe.
Sub category analysis ([stroke severity analysis by 
stroke etiology]):
We analyzed the relationship of different variables with 
stroke severity categories, in each stroke type / etiology. 
In this analysis  we found that only the Supra Aortic 
Large artery atherosclerosis and cryptogenic types 
([Table 4]) had the inverse relationship between stroke 
severity and triglyceride levels ([P = .04]). Apparently 
triglyceride levels did not produce similar effect on 
stroke severity in cardio aortic embolism and small 
vessel occlusion. In this sub category analysis, we also 
found that the pre-stroke anti platelet ([aspirin, 
clopidogrel or both]) and beta blocker use ([Table 5]) 
was significantly associated with lower stroke severity 
only in Supra Aortic Large artery atherosclerosis 
([P=.02]). In cardio aortic embolic strokes 10 patients 
were actively smoking out of which 6 patients suffered 
from severe stroke, 3 patients with moderate stroke 
and only one had mild stroke ([P=.03]).  
DISCUSSION:
In this exploratory study we compared many different 
characteristics of patients with acute ischemic stroke 
and analyzed them for their relationship with stroke 
severity. The stroke etiology / type, as is already known, 
was one of the main factors related to stroke severity 
([table 1]). The cardio aortic embolism and unclassified 
type (more than one etiology) were associated with 
more severe strokes, while supra aortic large artery 
atherosclerosis mostly with moderate severity and 
cryptogenic strokes, small artery occlusion, and 
may give us clues to look for novel neuroprotection and 
possibly disease modifying strategies. We designed our 
research work as an exploratory study, aiming to 
observe relationships between  the clinical, laboratory 
and radiological features, and stroke severity among 
ischemic stroke patients. We identified clinical 
characteristics that are usually evaluated for nearly all 
hospitalized patients suffering ischemic stroke, and 
analyzed them for any significant relationship with 
stroke severity as measured by NIHSS. Given possibility 
of confounding factors and limitations of NIHSS we 
restricted our study only for ischemic strokes in middle 
cerebral artery ([MCA]) distribution.
 
METHODS:
This study was designed as an exploratory retrospective 
cross sectional survey. It was carried out in the 
department of Neurology, at Shifa International 
Hospital, Islamabad, Pakistan which is one of the 
largest tertiary care hospitals in the capital city.  The 
research protocol was approved by the Institutional 
Review Board of the same hospital. Only adult patients 
([18 years and above]) admitted in the neurology 
service, with the diagnosis of acute Middle Cerebral 
Artery (MCA) ischemic stroke (territorial or lacunar 
infarcts in MCA distribution), within three days of onset 
of ischemic symptoms over a period of 39 months 
([September 2009 to November 2012]) were 
considered. During the study period Intravenous tissue 
plasminogen activator, acute endovascular 
intervention, were not available in our hospital, 
therefore none of the patients received acute 
thrombolytic therapy. Patients with posterior circulation 
ischemia, having history of previous stroke, and those 
suffering from any disabling neurological disease other 
than stroke were excluded as the patients with previous 
strokes, and having a baseline neurological deficit may 
have a more severe deficit, because of the recurrent 
stroke, which may not be related to the more acute 
laboratory findings that we measured. The file records 
of selected patients were extracted and relevant clinical 
information pertaining to first 24 hours of hospital 
admissions was obtained. The laboratory values were 
taken from Hospital Information System (HIS), and 
radiological data was reviewed from Picture Archiving 
and Communication System ([PACS]) of the hospital. 
For etiological classification of stroke the online 
Causative Classification of Ischemic Stroke ([CSS]) 
System was used 4. The information thus obtained was 
entered in a predesigned data sheet. At the completion 
of the data collection all the data was entered in SPSS 
20. All the case histories, laboratory data in first 24 
hours of admission, and radiological information was 
reviewed and analyzed by a consultant neurologist and 
statisticians.
Operational definitions: 
1. Acute MCA ischemic stroke: An acute event that was 
diagnosed by the attending neurologist as ischemic 
stroke ([with or without hemorrhagic conversion]) and 
corresponds to areas supplied by middle cerebral artery 
and/ or its smaller perforator branches which was 
further radiologically confirmed by MRI ([DWI/ ADC 
sequences]) or CT scans.
2. Co- morbid hypertension: The file records showed 
that the patient was known to be hypertensive and he 
was on regular anti-hypertensive therapy, or was found 
to have a blood pressure of 160 mmHg / 90 mmHg or 
more on admission, that was not considered by the 
attending physician as transient rise due to cerebral 
compensating mechanisms.
3. Co- morbid diabetes: The file records showed 
that the patient was known to be diabetic and he/ she 
was taking regular anti diabetic medications, or his 
HbA1c was 6.5 % or more.
4. Co – morbid Ischemic heart disease and 
chronic renal failure: The patient was labelled to have 
above mentioned co-morbid conditions in the file 
records, diagnosed on the basis of clinical, 
electrocardiographic, biochemical, echocardiographic 
and ultra-sonographic investigations.
Categories by stroke etiology / stroke type:
We utilized the online software, CCS ([which is derived 
from TOAST classification]) to determine the stroke type 
by its etiology. 4 However we made some modifications 
in this classification system, so that statistical analyses 
were possible as some of the categories had very low 
number of patients.  In the original CCS classification 
there are 5 major categories and 4 subcategories. But, 
in our study we merged some of the subcategories and 
thus made in total 6 categories ([without any 
subcategories]) at the time of analyses of the data 
([table 1]). The subtype “unknown – cryptogenic 
embolism” and “unknown- other cryptogenic” in CCS 
were also combined together into cryptogenic type. The 
category “Unclassified” was used when more than one 
etiologies are identifiable in the same patient ([same as 
in original CCS classification]).  
Categories by stroke severity: 
Determined by NIHSS score. They were as follows5 ;
Mild: < 5, Moderate: 5- 14, Severe: ≥ 15 
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uncommon causes were associated with predominantly 
lower stroke severity. Similar results have been shown 
in other studies6,7. Furthermore the triglyceride levels 
were found to be inversely related to stroke severity, as 
the higher triglyceride levels were significantly 
associated with lower stroke severity and vice versa 
([table 2 and figure 2]). In fact, the role of higher serum 
triglycerides in reducing the stroke severity is a relatively 
novel concept, as hypertriglyceridemia is considered a 
risk factor for stroke. The association of triglyceride 
levels in blood, with stroke severity and outcome has 
emerged in a few other recently published studies8. 
Dziedzic et al., correlated the Scandinavian stroke scale 
([which is another measure of stroke severity])  to 
triglyceride levels, and concluded that lower triglyceride 
levels were associated with increased stroke severity9. 
A prospective study by Ryu etal, reported that higher 
fasting triglycerides on admission predict less disability, 
reduced disability progression, and all-cause mortality 
in patients with acute ischemic stroke10. Another study 
by Choi etal also confirmed that low serum triglyceride 
level is an independent predictor of mortality after 
ischemic stroke, but noted that this association did not 
hold true in the subgroup with cardioembolic stroke11. 
History of dyslipidemia was found to have a favorable 
effect on out come in ischemic stroke patients in Kyoto 
stroke registry12.  In one study higher cholesterol levels 
were also reported to be associated more frequently 
with minor strokes13. Our study elaborates this unusual 
phenomenon, as we further analyzed the distribution of 
triglycerides levels among different stroke severity 
categories in each stroke etiology/ type. What appeared 
in this later analysis is that the effect of serum 
triglyceride levels (as mentioned above) was significant 
only in supra aortic large artery atherosclerosis and 
cryptogenic types (table 4). The other types including 
cardioaortic embolic and small artery occlusion stroke 
types were not affected by triglyceride levels. The loss 
of this triglyceride effect in cardio aortic embolic strokes 
was also seen by  Choi etal ([see above])11. Current 
stroke pathophysiology models do not explain this 
phenomenon, as hypertriglyceridemia is actually 
considered a risk factor for stroke because of its long 
term effects on vascular endothelium. There can be 
many explanations for this associations. (1) Some 
authors consider serum triglycerides as an acute phase 
reactant that is decreased in severe strokes as a result 
of cerebral ischemia and perhaps may not actually have 
a direct protective effect against cerebral neuronal 
damage8. (2) Another likely possibility, though 
debatable, is the fact that high lipid containing plaque / 
clot is very likely to be friable, and thus embolise easily 
into more distal cerebral vasculature thus it may cause 
more incident stroke but that of lesser severity.(3) There 
is also a possibility that high lipids especially 
triglycerides, may have a more positive role in acute 
ischemic strokes.  It is a well-known fact that fats in 
general have a favorable effect on brain metabolism. 
For example; fatty diets like ketogenic diet is well known 
to have a therapeutic effect in refractory epilepsy in 
children, 14 although similar diet has not been 
thoroughly evaluated in adults with stroke or epilepsy. 
Thus more research is needed to elucidate the role of 
lipids/ triglycerides in during the acute phases of 
ischemic stroke. In supra aortic large artery 
atherosclerotic strokes pre stroke antiplatelet (aspirin, 
clopidogrel or both) and beta blocker use was 
significantly associated with lower stroke severity 
([table 5]). Aspirin use before stroke has been shown to 
have a beneficial effect in some other studies as similar 
findings were reported by Park etal 15 in 
atherothrombotic stroke. Same effect could not be 
seen in cardio aortic embolism and other stroke types 
16,17. The effect of beta blockers (propranolol and 
carvedilol) on brain ischemia has been shown in 
experimental models of stroke that suggest a 
neuroprotective effect on cerebral neurons18-20. 
Dziedzic T et al, found lower rates of early mortality after 
ischemic stroke in patients taking beta blockers, 
however, they did not report any effect on stroke 
severity22. They did not take stroke etiology into 
account, in their patients. Active current smoking was 
also found to be related to increased stroke severity in 
cardioembolic stroke but not in other types. Similar 
findings were reported by Edjoc etal.22 Among the 
radiological features, it was the size and not the site of 
the infarction that was mainly associated with stroke 
severity ([table 3]). In plain CT brain and MRI scans the 
whole MCA territory and malignant MCA infarctions had 
significantly higher stroke severity, while among the 
different MRI DWI patterns we found only the large ([> 
15 mm in size]) pattern irrespective of the location 
(lobar or deep subcortical) had significant association 
with severe strokes.
Weaknesses:
The study was a retrospective analysis with an 
exploratory design. We preferred such a study design 
because; (1) we were not testing any hypothesis, rather 
we aimed to look into possible novel strategies for 
neuroprotection that might generate newer 
studies.(2)The authors found it more feasible because 
of the limited resources at their disposal. Furthermore, 
a multivariate analysis could not be performed for 
specification of potential confounding effect and 
predictors of stroke severity due to design of study. 
Rather, we used restriction and stratification 
strategies in data selection and analysis to control for 
possible confounders. 
We also did not have the pre stroke or baseline 
triglyceride levels of our subjects, which was 
practically not possible either, therefore the theory of 
acute phase reaction to explain the inverse 




In spite of all the weaknesses we think that this study 
provides valuable information. Furthermore we 
analyzed our variables in different subsets and found 
that the relationship between stroke severity and 
triglyceride levels, pre-stroke anti platelet as well as 
beta blocker use and smoking, seemingly depends 
upon the etiological category of the stroke, a fact not 
particularly looked into as yet.
CONCLUSION:
Stroke severity is related to age and its etiology. There 
is also a possible inverse correlation between stroke 
severity and fasting triglyceride levels, which is seen 
predominantly in supra aortic large artery 
atherosclerotic and cryptogenic stroke etiologies. 
People who suffer ischemic strokes due to supra 
aortic large artery atherosclerosis, with pre-stroke use 
of anti-platelets and beta blockers, also seem to have 
a reduced stroke severity. Furthermore, patients who 
actively smoke may have more severe strokes, if they 
have a cardio embolic etiology. We would recommend 
future studies to verify if factors we found have a 
consistent causal association, in the context of 
different stroke etiologies.  
Table 1: stroke severity by categories vs stroke 
etiology.
*Shows statistically significant proportion of severity 
of stroke with stroke types (P<.001)
Figure 1 : Mean NIHSS score Difference 
according to stroke etiology
Bar graph showing significant mean NIHSS score 
associated with stroke sub-types ([F= 6.317, 
P=.001]). Cardio aortic embolic strokes and 
unclassified strokes had the highest severity. 
Table 2 : stroke severity as compared to different 
variables:
Stroke etiology NIHSS at admission categorized Total 
Mild (<5) Moderate 
(5-14) 
Severe (  
15) 
Supra aortic Large artery 
atherosclerosis 33 (33.7%)* 44 (44.9%)* 21 (21.4%) 98 
Cardio aortic embolism 8 (20.0%) 21(52.5%)* 11 (27.5%)* 40 
Small artery occlusion 17 (77.3%)* 5 (22.7%) 0 (0.0%) 22 
Cryptogenic type 13 (61.9%)* 8 (38.1%) 0 (0.0%) 21 
unclassified 4 (20.0%) 10 (50.0%)* 6 (30.0%)* 20 
Uncommon causes 3 (60.0%) 2 (40.0%) 0 (0.0%) 5 
Total 78 (37.9%) 90 (43.7%) 38 (18.4%) 206 
Demographics Mild Moderate Severe  P – value 
Mean age  60.6 65.7 64.5 .04 
Sex  Female  31 (34.4%) 45 (50 %) 14 (15%) .25 
Male  48 (41%) 45 (38.4 %) 24 (20.5%) 
Occupational 
status 
Employed 16 (53.3 %) 8 (26.7%) 6 (20%) .07 
Unemployed 52 (32.7%) 75(47.1%) 32(20.1%) 
Marital status Single 0 (0%) 3 (75 %) 1 (25 %) .35 
Married 67 (40 %) 70 (41.6%) 31 (18.5 %) 
Widow 6 (25 %) 13 (54.2 %) 5 (20.8 %) 
Co- morbid conditions 
Diabetes mellitus 41 (40 %) 42 (41.1 %) 19 (18.6 %) .40 
Hypertension  57 (40.4%) 58 (41%) 26 (18.4%) .60 
Ischemic heart disease  14 (29.2%) 20 (41.7%) 14 (29.2%) .07 
Smoking (current) 20 (37.7 %) 19 (35.8%) 14 (26.4 %)  .18 
Chronic renal failure 4 (57.1 %) 2 (28.6 %) 1 (14.3%) .57 
Other baseline values (means) 
Systolic BP (mean value 
during first 6hrs of 
presentation) 
142.2 142.95 144 .91 
RBS 177.25 155.77 170.86 .31 
HbA1c 7.8 7.51 8.64 .14 
Triglycerides 196 145.5 137.7 .002 
Total cholesterol 172.5 180.5 186.5 .279 
HDL cholesterol 35.5 39.1 38 .120 
LDL cholesterol 109.5 117.5 127.7 .065 
 
Figure 2 : Scatter plot showing inverse relationship 
between NIHSS at admission and triglyceride 
levels
Table 3 : Radiological features vs stroke severity
*significant values.
Table 4 : Mean Triglyceride levels in different 
stroke categories
Table 5: impact of pre-stroke medicines and stroke 
severity
a Statistical significance using Pearson’s chi-square 
test b Fischer’s exact test.
Statistical analysis:
Data analysis was done by using SPSS version-20.0 
([IBM Product-USA]). The categorical response 
variables included patient’s demographic features, 
etiology of stroke, co- morbid conditions, family history, 
clinical features and severity of stroke. The numeric 
response variables like fasting triglyceride and other 
lipid levels, HbA1c, random blood sugar ([RBS]), 
Systolic Blood Pressure, and fasting lipid profile were 
presented as mean (standard deviation). Analysis of 
variance ([ANOVA]) was performed to compare these 
numeric response variables. Later, these numeric 
variables were stratified in order to control the 
confounding effect and effect modifiers. Stroke severity 
was also stratified into three categories i.e., mild, 
moderate and severe. Bivariate analysis by using 
Chi-square test was done to see relationship of 
aforementioned variables with the severity of stroke 
measured by NIHSS and divided into categories. 
Pearson’s correlation coefficient was calculated to see 
the relationship of triglyceride level with the NIHSS. 
P-value ≤.05 was considered statistically significant 
result.
RESULTS:
Baseline characteristics of patients:
Total 207 patients were selected after applying the 
inclusion and exclusion criteria. The mean ([SD]) age of 
patients was 63.5 ([13.7]) yrs. ([range 26 yrs. – 95 
yrs.]). There were 117 ([56.5 %]) males and 90 ([43.5 
%]) females. Among males mean ([SD]) age was 64.1 
([13.6]) yrs., and that of females was 62.8 ([13.8]) 
yrs.The age distribution was not uniform among 
different stroke etiologies. The mean age in unclassified 
stroke type ([more than one etiologies]) was 70 yrs. 
that was highest than the rest of stroke types, while the 
mean age in uncommon causes of stroke was 34 years 
that was significantly lower than the other stroke types. 
According to stroke etiology most of the patients were 
in supra aortic large artery atherosclerosis that totaled 
98 ([47.3%]) patients, followed by, Cardio embolism in 
40 ([19.3%]) patients, small artery occlusion in 22 
([10.6 %]) patients, cryptogenic type in 21 ([10.1 %]), 
unclassified in 20 ([9.7 %]),  and uncommon causes in 
5 ([2.4 %]), of patients. One patient had incomplete 
evaluation.
Stroke severity analysis:
When stroke severity was taken as mean NIHSS or as 
NIHSS categories ([mild, moderate or severe]), the 
results appeared similar (see Table 1 and figure 1). 
Higher number of patients were in moderate to severe 
category in cardio  embolic strokes ([mean NIHSS 
10.4]) and unclassified ([mean NIHSS 9.3]) stroke 
types. Small vessel occlusion type strokes had the 
lowest severity. When stroke severity ([mean NIHSS 
and/or NIHSS categories]) was compared with all 
variables other than stroke etiology, significant 
associations were found only with age and fasting 
triglyceride levels. Stroke severity was found to be 
higher with advancing age.  NIHSS scores were 
significantly lower with higher triglyceride levels and vice 
versa. ([see table 2 and figure 2]). When radiological 
features were compared to stroke severity ([Table 3]) it 
was found that higher stroke severity was associated 
with whole MCA territory / malignant MCA infarctions, 
while partial MCA infarctions were less severe. MRI DWI 
(Diffusion Weighted Imaging) assessment showed that 
large sized infarctions with more than 15 mm size 
([territorial, lobar or deep subcortical]) and those with 
hemorrhagic conversion, were more likely to be 
moderate or severe.
Sub category analysis ([stroke severity analysis by 
stroke etiology]):
We analyzed the relationship of different variables with 
stroke severity categories, in each stroke type / etiology. 
In this analysis  we found that only the Supra Aortic 
Large artery atherosclerosis and cryptogenic types 
([Table 4]) had the inverse relationship between stroke 
severity and triglyceride levels ([P = .04]). Apparently 
triglyceride levels did not produce similar effect on 
stroke severity in cardio aortic embolism and small 
vessel occlusion. In this sub category analysis, we also 
found that the pre-stroke anti platelet ([aspirin, 
clopidogrel or both]) and beta blocker use ([Table 5]) 
was significantly associated with lower stroke severity 
only in Supra Aortic Large artery atherosclerosis 
([P=.02]). In cardio aortic embolic strokes 10 patients 
were actively smoking out of which 6 patients suffered 
from severe stroke, 3 patients with moderate stroke 
and only one had mild stroke ([P=.03]).  
DISCUSSION:
In this exploratory study we compared many different 
characteristics of patients with acute ischemic stroke 
and analyzed them for their relationship with stroke 
severity. The stroke etiology / type, as is already known, 
was one of the main factors related to stroke severity 
([table 1]). The cardio aortic embolism and unclassified 
type (more than one etiology) were associated with 
more severe strokes, while supra aortic large artery 
atherosclerosis mostly with moderate severity and 
cryptogenic strokes, small artery occlusion, and 
may give us clues to look for novel neuroprotection and 
possibly disease modifying strategies. We designed our 
research work as an exploratory study, aiming to 
observe relationships between  the clinical, laboratory 
and radiological features, and stroke severity among 
ischemic stroke patients. We identified clinical 
characteristics that are usually evaluated for nearly all 
hospitalized patients suffering ischemic stroke, and 
analyzed them for any significant relationship with 
stroke severity as measured by NIHSS. Given possibility 
of confounding factors and limitations of NIHSS we 
restricted our study only for ischemic strokes in middle 
cerebral artery ([MCA]) distribution.
 
METHODS:
This study was designed as an exploratory retrospective 
cross sectional survey. It was carried out in the 
department of Neurology, at Shifa International 
Hospital, Islamabad, Pakistan which is one of the 
largest tertiary care hospitals in the capital city.  The 
research protocol was approved by the Institutional 
Review Board of the same hospital. Only adult patients 
([18 years and above]) admitted in the neurology 
service, with the diagnosis of acute Middle Cerebral 
Artery (MCA) ischemic stroke (territorial or lacunar 
infarcts in MCA distribution), within three days of onset 
of ischemic symptoms over a period of 39 months 
([September 2009 to November 2012]) were 
considered. During the study period Intravenous tissue 
plasminogen activator, acute endovascular 
intervention, were not available in our hospital, 
therefore none of the patients received acute 
thrombolytic therapy. Patients with posterior circulation 
ischemia, having history of previous stroke, and those 
suffering from any disabling neurological disease other 
than stroke were excluded as the patients with previous 
strokes, and having a baseline neurological deficit may 
have a more severe deficit, because of the recurrent 
stroke, which may not be related to the more acute 
laboratory findings that we measured. The file records 
of selected patients were extracted and relevant clinical 
information pertaining to first 24 hours of hospital 
admissions was obtained. The laboratory values were 
taken from Hospital Information System (HIS), and 
radiological data was reviewed from Picture Archiving 
and Communication System ([PACS]) of the hospital. 
For etiological classification of stroke the online 
Causative Classification of Ischemic Stroke ([CSS]) 
System was used 4. The information thus obtained was 
entered in a predesigned data sheet. At the completion 
of the data collection all the data was entered in SPSS 
20. All the case histories, laboratory data in first 24 
hours of admission, and radiological information was 
reviewed and analyzed by a consultant neurologist and 
statisticians.
Operational definitions: 
1. Acute MCA ischemic stroke: An acute event that was 
diagnosed by the attending neurologist as ischemic 
stroke ([with or without hemorrhagic conversion]) and 
corresponds to areas supplied by middle cerebral artery 
and/ or its smaller perforator branches which was 
further radiologically confirmed by MRI ([DWI/ ADC 
sequences]) or CT scans.
2. Co- morbid hypertension: The file records showed 
that the patient was known to be hypertensive and he 
was on regular anti-hypertensive therapy, or was found 
to have a blood pressure of 160 mmHg / 90 mmHg or 
more on admission, that was not considered by the 
attending physician as transient rise due to cerebral 
compensating mechanisms.
3. Co- morbid diabetes: The file records showed 
that the patient was known to be diabetic and he/ she 
was taking regular anti diabetic medications, or his 
HbA1c was 6.5 % or more.
4. Co – morbid Ischemic heart disease and 
chronic renal failure: The patient was labelled to have 
above mentioned co-morbid conditions in the file 
records, diagnosed on the basis of clinical, 
electrocardiographic, biochemical, echocardiographic 
and ultra-sonographic investigations.
Categories by stroke etiology / stroke type:
We utilized the online software, CCS ([which is derived 
from TOAST classification]) to determine the stroke type 
by its etiology. 4 However we made some modifications 
in this classification system, so that statistical analyses 
were possible as some of the categories had very low 
number of patients.  In the original CCS classification 
there are 5 major categories and 4 subcategories. But, 
in our study we merged some of the subcategories and 
thus made in total 6 categories ([without any 
subcategories]) at the time of analyses of the data 
([table 1]). The subtype “unknown – cryptogenic 
embolism” and “unknown- other cryptogenic” in CCS 
were also combined together into cryptogenic type. The 
category “Unclassified” was used when more than one 
etiologies are identifiable in the same patient ([same as 
in original CCS classification]).  
Categories by stroke severity: 
Determined by NIHSS score. They were as follows5 ;
Mild: < 5, Moderate: 5- 14, Severe: ≥ 15 
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uncommon causes were associated with predominantly 
lower stroke severity. Similar results have been shown 
in other studies6,7. Furthermore the triglyceride levels 
were found to be inversely related to stroke severity, as 
the higher triglyceride levels were significantly 
associated with lower stroke severity and vice versa 
([table 2 and figure 2]). In fact, the role of higher serum 
triglycerides in reducing the stroke severity is a relatively 
novel concept, as hypertriglyceridemia is considered a 
risk factor for stroke. The association of triglyceride 
levels in blood, with stroke severity and outcome has 
emerged in a few other recently published studies8. 
Dziedzic et al., correlated the Scandinavian stroke scale 
([which is another measure of stroke severity])  to 
triglyceride levels, and concluded that lower triglyceride 
levels were associated with increased stroke severity9. 
A prospective study by Ryu etal, reported that higher 
fasting triglycerides on admission predict less disability, 
reduced disability progression, and all-cause mortality 
in patients with acute ischemic stroke10. Another study 
by Choi etal also confirmed that low serum triglyceride 
level is an independent predictor of mortality after 
ischemic stroke, but noted that this association did not 
hold true in the subgroup with cardioembolic stroke11. 
History of dyslipidemia was found to have a favorable 
effect on out come in ischemic stroke patients in Kyoto 
stroke registry12.  In one study higher cholesterol levels 
were also reported to be associated more frequently 
with minor strokes13. Our study elaborates this unusual 
phenomenon, as we further analyzed the distribution of 
triglycerides levels among different stroke severity 
categories in each stroke etiology/ type. What appeared 
in this later analysis is that the effect of serum 
triglyceride levels (as mentioned above) was significant 
only in supra aortic large artery atherosclerosis and 
cryptogenic types (table 4). The other types including 
cardioaortic embolic and small artery occlusion stroke 
types were not affected by triglyceride levels. The loss 
of this triglyceride effect in cardio aortic embolic strokes 
was also seen by  Choi etal ([see above])11. Current 
stroke pathophysiology models do not explain this 
phenomenon, as hypertriglyceridemia is actually 
considered a risk factor for stroke because of its long 
term effects on vascular endothelium. There can be 
many explanations for this associations. (1) Some 
authors consider serum triglycerides as an acute phase 
reactant that is decreased in severe strokes as a result 
of cerebral ischemia and perhaps may not actually have 
a direct protective effect against cerebral neuronal 
damage8. (2) Another likely possibility, though 
debatable, is the fact that high lipid containing plaque / 
clot is very likely to be friable, and thus embolise easily 
into more distal cerebral vasculature thus it may cause 
more incident stroke but that of lesser severity.(3) There 
is also a possibility that high lipids especially 
triglycerides, may have a more positive role in acute 
ischemic strokes.  It is a well-known fact that fats in 
general have a favorable effect on brain metabolism. 
For example; fatty diets like ketogenic diet is well known 
to have a therapeutic effect in refractory epilepsy in 
children, 14 although similar diet has not been 
thoroughly evaluated in adults with stroke or epilepsy. 
Thus more research is needed to elucidate the role of 
lipids/ triglycerides in during the acute phases of 
ischemic stroke. In supra aortic large artery 
atherosclerotic strokes pre stroke antiplatelet (aspirin, 
clopidogrel or both) and beta blocker use was 
significantly associated with lower stroke severity 
([table 5]). Aspirin use before stroke has been shown to 
have a beneficial effect in some other studies as similar 
findings were reported by Park etal 15 in 
atherothrombotic stroke. Same effect could not be 
seen in cardio aortic embolism and other stroke types 
16,17. The effect of beta blockers (propranolol and 
carvedilol) on brain ischemia has been shown in 
experimental models of stroke that suggest a 
neuroprotective effect on cerebral neurons18-20. 
Dziedzic T et al, found lower rates of early mortality after 
ischemic stroke in patients taking beta blockers, 
however, they did not report any effect on stroke 
severity22. They did not take stroke etiology into 
account, in their patients. Active current smoking was 
also found to be related to increased stroke severity in 
cardioembolic stroke but not in other types. Similar 
findings were reported by Edjoc etal.22 Among the 
radiological features, it was the size and not the site of 
the infarction that was mainly associated with stroke 
severity ([table 3]). In plain CT brain and MRI scans the 
whole MCA territory and malignant MCA infarctions had 
significantly higher stroke severity, while among the 
different MRI DWI patterns we found only the large ([> 
15 mm in size]) pattern irrespective of the location 
(lobar or deep subcortical) had significant association 
with severe strokes.
Weaknesses:
The study was a retrospective analysis with an 
exploratory design. We preferred such a study design 
because; (1) we were not testing any hypothesis, rather 
we aimed to look into possible novel strategies for 
neuroprotection that might generate newer 
studies.(2)The authors found it more feasible because 
of the limited resources at their disposal. Furthermore, 
a multivariate analysis could not be performed for 
specification of potential confounding effect and 
predictors of stroke severity due to design of study. 
Rather, we used restriction and stratification 
strategies in data selection and analysis to control for 
possible confounders. 
We also did not have the pre stroke or baseline 
triglyceride levels of our subjects, which was 
practically not possible either, therefore the theory of 
acute phase reaction to explain the inverse 




In spite of all the weaknesses we think that this study 
provides valuable information. Furthermore we 
analyzed our variables in different subsets and found 
that the relationship between stroke severity and 
triglyceride levels, pre-stroke anti platelet as well as 
beta blocker use and smoking, seemingly depends 
upon the etiological category of the stroke, a fact not 
particularly looked into as yet.
CONCLUSION:
Stroke severity is related to age and its etiology. There 
is also a possible inverse correlation between stroke 
severity and fasting triglyceride levels, which is seen 
predominantly in supra aortic large artery 
atherosclerotic and cryptogenic stroke etiologies. 
People who suffer ischemic strokes due to supra 
aortic large artery atherosclerosis, with pre-stroke use 
of anti-platelets and beta blockers, also seem to have 
a reduced stroke severity. Furthermore, patients who 
actively smoke may have more severe strokes, if they 
have a cardio embolic etiology. We would recommend 
future studies to verify if factors we found have a 
consistent causal association, in the context of 
different stroke etiologies.  
Table 1: stroke severity by categories vs stroke 
etiology.
*Shows statistically significant proportion of severity 
of stroke with stroke types (P<.001)
Figure 1 : Mean NIHSS score Difference 
according to stroke etiology
Bar graph showing significant mean NIHSS score 
associated with stroke sub-types ([F= 6.317, 
P=.001]). Cardio aortic embolic strokes and 
unclassified strokes had the highest severity. 
Table 2 : stroke severity as compared to different 
variables:
Figure 2 : Scatter plot showing inverse relationship 
between NIHSS at admission and triglyceride 
levels
Table 3 : Radiological features vs stroke severity
*significant values.
Table 4 : Mean Triglyceride levels in different 
stroke categories
Table 5: impact of pre-stroke medicines and stroke 
severity
a Statistical significance using Pearson’s chi-square 
test b Fischer’s exact test.
Lacunar infarct (MCA 
perforator) 
17 (21.8)* 7 (7.8) 0 (0) .011 
Partial MCA   54 (69.0)* 56 ( 62.2) 15 ( 39.5) .018 
Whole MCA 0 (0) 8 (8.9) 8 (21.0)* .028 
     
DWI patterns 
Large ( > 15 mm) 6 (7.7) 38 (42.2)* 14 (36.8)* .001 
Small superficial 17 (21.8)* 2 (2.2) 0 (0.0) .001 
Cortical mixed patterns 16(20.5) 21 (23.3) 7 (18.4) .736 
Small deep 7 (9.0) 3 (3.3) 0 (0) .083 
Water shed infarcts 7 (9.0)* 2 (2.2) 1 (2.6) .046 
Hemorrhagic conversion 1 (1.3) 4 (4.4) 4 (10.5)* .007 
Vascular  territory  
(CT and MRI brain) 
Mild 
(n = 78) 
Moderate 
(n = 90) 
Severe 
(n = 38) 
P- value 
Antiplatelet use : 
 Mild Moderate Severe P-value 
Supra aortic Large artery 
atherosclerosis 
14 (52 %) 6 (22.2 %) 7 (25.9 %) .02a 
Cardio aortic embolism 1 (10 %) 6 (60%) 3 (30%) .12 a 
Small artery occlusion 3 (60%) 2(40%) 0 .29 a 
Cryptogenic  3 (100%) 0 0 .14 a 
Unclassified  1 (14.3%) 5 (71.4%) 1 (14.3%) .36 a 
Uncommon causes  1 (50%) 1(50%) 0 .70 a 
Beta- blocker use: 
 Mild Moderate Severe P-value 
Supra aortic Large artery 
atherosclerosis 
15 (53.6 %) 10 (35.7%) 3 (10.7 %) .02a 
Cardio aortic embolism 4 (40 %) 3 (30 %) 3 (30%) .66a 
Small artery occlusion 2(50%) 2(50%) 0 .21b 
Cryptogenic  3 (100%) 0 0 .21b 
Unclassified  1 (14.3%) 5 (71.4%) 1 (14.3%) .36a 
Uncommon causes  0 1 (100%) 0 .59a 
 
Stroke types Mild Moderate Severe P- value 
Supra aortic large artery 
atherosclerosis 212.18 149.00 156.42 .04 
Cardio aortic  embolism  142.71 133.72 116.45 .74 
Small artery occlusion 174.75 184.60 -- .85 
Cryptogenic  216.08 141.86 -- .04 
Unclassified  152.00 111.78 107.25 .49 
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